In one paragraphArticle in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
12 authors.
Manoj MadheswaranDepartment of Environmental, Biological and Pharmaceutical Sciences and Technologies (DISTABiF), Università degli Studi della Campania Luigi Vanvitelli, 81100 Caserta, Italy.ORCID 0009-0005-9642-571X Nataliia VentserovaDepartment of Environmental, Biological and Pharmaceutical Sciences and Technologies (DISTABiF), Università degli Studi della Campania Luigi Vanvitelli, 81100 Caserta, Italy.
Gianluca D'AbroscaDepartment of Clinical and Experimental Medicine, Università degli Studi di Foggia, 71122 Foggia, Italy.ORCID 0000-0002-1786-4249 Giulia SalzanoDepartment of Neuroscience, Scuola Internazionale Superiore di Studi Avanzati, 34136 Trieste, Italy.
Luigi CelauroDepartment of Neuroscience, Scuola Internazionale Superiore di Studi Avanzati, 34136 Trieste, Italy.ORCID 0000-0002-5731-3257 Federico Angelo CazzanigaDivision of Neurology 5-Neuropathology, Fondazione IRCCS Istituto Neurologico Carlo Besta, 20133 Milan, Italy.
Carla IserniaDepartment of Environmental, Biological and Pharmaceutical Sciences and Technologies (DISTABiF), Università degli Studi della Campania Luigi Vanvitelli, 81100 Caserta, Italy.ORCID 0000-0002-1504-2479 Gaetano MalgieriDepartment of Environmental, Biological and Pharmaceutical Sciences and Technologies (DISTABiF), Università degli Studi della Campania Luigi Vanvitelli, 81100 Caserta, Italy.ORCID 0000-0002-4070-9458 Fabio ModaSSD Laboratory Medicine, Fondazione IRCCS Istituto Neurologico Carlo Besta, 20133 Milan, Italy.ORCID 0000-0002-2820-9880 Luigi RussoDepartment of Environmental, Biological and Pharmaceutical Sciences and Technologies (DISTABiF), Università degli Studi della Campania Luigi Vanvitelli, 81100 Caserta, Italy.ORCID 0000-0002-1577-176X Giuseppe LegnameDepartment of Neuroscience, Scuola Internazionale Superiore di Studi Avanzati, 34136 Trieste, Italy.
Roberto FattorussoDepartment of Environmental, Biological and Pharmaceutical Sciences and Technologies (DISTABiF), Università degli Studi della Campania Luigi Vanvitelli, 81100 Caserta, Italy.
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
The pathological process of prion diseases implicates that the normal physiological cellular prion protein (PrP
Indexed as
Prion ProteinsProtein UnfoldingAmyloidHumansProtein FoldingTemperatureAmyloidPrion Proteinsamyloid fibrilsFicollmolecular crowdingprion proteinthermal unfolding
Identifiers
PMID39337404
PMCPMC11432716
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390